Prospects for combining targeted and conventional cancer therapy with immunotherapy
Nature Reviews Cancer 17, 286 (2017).
doi:10.1038/nrc.2017.17
Authors: Philip Gotwals, Scott Cameron, Daniela Cipolletta, Viviana Cremasco, Adam Crystal, Becker Hewes, Britta Mueller, Sonia Quaratino, Catherine Sabatos-Peyton, Lilli Petruzzelli, Jeffrey A. Engelman & Glenn Dranoff
Over the past 25 years, research in cancer therapeutics has largely focused on two distinct lines of enquiry. In one approach, efforts to understand the underlying cell-autonomous, genetic drivers of tumorigenesis have led to the development of clinically important targeted agents that result in profound,
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Philip Gotwals Scott Cameron Daniela Cipolletta Viviana Cremasco Adam Crystal Becker Hewes Britta Mueller Sonia Quaratino Catherine Sabatos-Peyton Lilli Petruzzelli Jeffrey A. Engelman Glenn Dranoff Tags: Review Source Type: research